Long-term immunity after BNT162b2 mRNA COVID-19 vaccination in pediatric patients with cancer

• K.L. Juliëtte Schmidt,
• Noortje R. Severeijns,
• Noël M.M. Dautzenberg,
• Peter M. Hoogerbrugge,
• Caroline A. Lindemans,
• Stefan Nierkens,
• Gaby Smits,
• Rob S. van Binnendijk,
• Marta Fiocco,
• Louis J. Bont,
• Wim J.E. Tissing

Affiliations

K.L. Juliëtte Schmidt

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Correspondence to: Princess Máxima Center for Pediatric Oncology, PO box 113, Bilthoven 3720 AC, the Netherlands.

Noortje R. Severeijns

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands

Noël M.M. Dautzenberg

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands

Peter M. Hoogerbrugge

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands

Caroline A. Lindemans

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands

Stefan Nierkens

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands

Gaby Smits

Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, the Netherlands

Rob S. van Binnendijk

Centre for Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, the Netherlands

Marta Fiocco

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Mathematical Institute Leiden University, Leiden, the Netherlands; Department of Biomedical Data Science, Section Medical Statistics, Leiden University Medical Centre, Leiden, the Netherlands

Louis J. Bont

Department of Pediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands

Wim J.E. Tissing

Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pediatric Oncology and Hematology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands